These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 24813579)

  • 1. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
    Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
    Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential expression of p-mTOR in cutaneous basal and squamous cell carcinomas likely explains their different response to mTOR inhibitors in organ-transplant recipients.
    Karayannopoulou G; Euvrard S; Kanitakis J
    Anticancer Res; 2013 Sep; 33(9):3711-4. PubMed ID: 24023300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
    Perbos E; Juinier E; Guidicelli G; Dromer C; Merville P; Billes MA; Taupin JL; Neau-Cransac M
    Clin Transplant; 2014 Sep; 28(9):1054-60. PubMed ID: 25040585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing.
    Feldmeyer L; Hofbauer GF; Böni T; French LE; Hafner J
    Br J Dermatol; 2012 Feb; 166(2):422-4. PubMed ID: 21895616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus and secondary skin-cancer prevention in kidney transplantation.
    Euvrard S; Morelon E; Rostaing L; Goffin E; Brocard A; Tromme I; Broeders N; del Marmol V; Chatelet V; Dompmartin A; Kessler M; Serra AL; Hofbauer GF; Pouteil-Noble C; Campistol JM; Kanitakis J; Roux AS; Decullier E; Dantal J;
    N Engl J Med; 2012 Jul; 367(4):329-39. PubMed ID: 22830463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Barysch MJ
    Praxis (Bern 1994); 2016 Sep; 105(18):1071-7. PubMed ID: 27606914
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
    Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
    Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
    JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of mTOR inhibitors on the development of malignancy.
    Geissler EK
    Transplant Proc; 2008 Dec; 40(10 Suppl):S32-5. PubMed ID: 19100904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibitor monotherapy. A good treatment choice in renal transplantation?
    Franco-Esteve A; Tordera D; de la Sen ML; Jiménez L; Mas P; Muñoz C; Olivares J
    Nefrologia; 2012; 32(5):631-8. PubMed ID: 23013949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
    Leblanc KG; Hughes MP; Sheehan DJ
    Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of non-melanocytic skin tumors].
    Hafner J
    Ther Umsch; 1998 Aug; 55(8):515-21. PubMed ID: 9757819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical insights for cancer outcomes in renal transplant patients.
    Alberú J
    Transplant Proc; 2010 Nov; 42(9 Suppl):S36-40. PubMed ID: 21095450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.
    Dantal J; Morelon E; Rostaing L; Goffin E; Brocard A; Tromme I; Broeders N; Del Marmol V; Chatelet V; Dompmartin A; Kessler M; Serra A; Hofbauer GFL; Kamar N; Pouteil-Noble C; Kanitakis J; Roux A; Decullier E; Euvrard S;
    J Clin Oncol; 2018 Sep; 36(25):2612-2620. PubMed ID: 30016177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    de Fijter JW
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.